Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. V. Retinal telangiectasis.

× No keyword cloud information.

16 in total

1. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.

Authors: Daniel Pauleikhoff; Roberto Bonelli; Adam M Dubis; Frederic Gunnemann; Kai Rothaus; Peter Charbel Issa; Tjebo Fc Heeren; Tunde Peto; Traci E Clemons; Emily Y Chew; Alan C Bird; Ferenc B Sallo
Journal: Acta Ophthalmol Date: 2019-04-09 Impact factor: 3.761

2. Coats' disease and congenital vascular retinopathy.

Authors: F P Campbell
Journal: Trans Am Ophthalmol Soc Date: 1976

3. The treatment of intraretinal angiomas.

Authors: P R McDonald; L K Sarin
Journal: Trans Am Ophthalmol Soc Date: 1970

4. Organised macular plaques in exudative diabetic maculopathy.

Authors: R Sigurdsson; I S Begg
Journal: Br J Ophthalmol Date: 1980-06 Impact factor: 4.638

5. Bevacizumab in the treatment of idiopathic macular telangiectasia.

Authors: Maria-Andreea Gamulescu; Andreas Walter; Helmut Sachs; Horst Helbig
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-04-02 Impact factor: 3.117

6. Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors: Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal: Middle East Afr J Ophthalmol Date: 2010-07

7. Large capillary aneurysms secondary to retinal venous obstruction.

Authors: J Schulman; L M Jampol; M F Goldberg
Journal: Br J Ophthalmol Date: 1981-01 Impact factor: 4.638

8. The National Eye Institute Visual Function Questionnaire in the Macular Telangiectasia (MacTel) Project.

Authors: Traci E Clemons; Mark C Gillies; Emily Y Chew; Alan C Bird; Tunde Peto; Maria Figueroa; Molly W Harrington
Journal: Invest Ophthalmol Vis Sci Date: 2008-06-27 Impact factor: 4.799

Review 9. Macular telangiectasia type 2.

Authors: Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal: Prog Retin Eye Res Date: 2012-12-03 Impact factor: 21.198

10. Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.

Authors: Eric J Sigler; John C Randolph; Jorge I Calzada; Steve Charles
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2012-09-06 Impact factor: 3.117